3 Reasons Why Growth Investors Shouldn't Overlook Zurn Water (ZWS)

Zurn Water (ZWS) is rated Zacks Rank #2 (Buy) with a Growth Score of B. EPS is projected to grow 20.4% this year versus 10.6% for the industry, while sales are expected to rise 9.5% versus 4.7%; its asset utilization ratio is 0.66 compared with the industry’s 0.54. The current-year consensus earnings estimate increased 0.3% over the past month, supporting the article’s favorable growth outlook.

Analysis

The case rests on forecast earnings acceleration, but the estimate-revision signal is thin: a 0.3% upward move does not independently validate the much stronger EPS-growth forecast. Asset turnover is not a margin or cash-conversion measure; it can look favorable without proving pricing power or durable incremental returns. The key underwriting question is whether growth is organic and supported by volume, mix, and operating margins—not merely a favorable screen.

Over 1–3 months, the catalyst is earnings and guidance: evidence of resilient orders, organic sales, and margin conversion could sustain estimate upgrades. In 6–18 months, water-system replacement and efficiency needs may support demand, but project timing and non-residential construction exposure can make the path cyclical. Adjacent names such as Watts Water Technologies (WTS), Mueller Water Products (MWA), and A. O. Smith (AOS) offer useful read-throughs, but differ in product and end-market mix; relative performance should not be treated as a clean valuation comparison.

Contrarian point: a Growth Score and high sales-to-assets ratio may screen well while missing valuation risk and the gap between forecast growth and actual cash generation. Without valuation, organic-growth, backlog/order, and margin data, the article supports a watchlist—not a standalone buy signal.

Key Decisions for Investors

• Do not chase ZWS on the screen-based case alone. Before adding exposure, verify the current valuation, organic versus acquired sales growth, order/backlog trends, and operating-margin and free-cash-flow conversion.
• Set an earnings catalyst watch for the next 1–3 months: upgrade the thesis only if reported demand and guidance support continued estimate increases alongside stable or improving margins. A pause in revisions or weaker orders would undercut the growth narrative.
• If those confirmations emerge, consider a modest relative-value long ZWS versus a broad building-products exposure such as XHB to isolate company execution from a weaker construction tape; define risk around guidance reductions or margin deterioration rather than assuming the growth forecast is secured.
• Falsify the thesis if organic sales decelerate materially, margins fail to convert sales growth into earnings, or estimates begin moving down. Reassess the longer-term case if construction weakness persists or water-efficiency/replacement demand fails to translate into orders.